| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5546720 | Actualités Pharmaceutiques | 2017 | 8 Pages |
Abstract
Tuberculosis is an infectious disease for which a treatment is available. This treatment follows a particular regimen which takes into account the slow, intracellular growth of the Koch bacillus, the physiopathology of the disease and the fast acquisition of resistance to antitubercular antibiotics through mutations.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Marine (Docteur en pharmacie), Julia (Pneumologue, médecin du Clat), Boris (Pneumologue, chef de service de pathologie respiratoire),